Clinical trial
Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell…
NCT00003606 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00003606 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer |
| Official title | Phase III Randomized Study of Cisplatin and Etoposide With or Without Epirubicin and Cyclophosphamide for Extensive Stage Small Cell Lung Cancer |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | cisplatin, cyclophosphamide, epirubicin hydrochloride, etoposide, radiation therapy |
| Enrollment | 216 |
| Start date | Mar 1, 1996 |
| Primary completion | Oct 1, 1999 |
| Completion | Jun 1, 2001 |
| First posted | May 21, 2004 |
| Last update posted | Feb 21, 2021 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: